Abbott Laboratories (ABT)
 NYSE: ABT · Real-Time Price · USD
 123.62
 -1.05 (-0.84%)
  At close: Oct 31, 2025, 4:00 PM EDT
123.97
 +0.35 (0.28%)
  After-hours: Oct 31, 2025, 6:08 PM EDT
Abbott Laboratories Employees
Abbott Laboratories had 114,000 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees 
 114,000
Change (1Y) 
 n/a
Growth (1Y) 
 n/a
Revenue / Employee 
 $384,588
Profits / Employee 
 $122,158
Market Cap 
214.96B
Employees Chart
Employees History
| Date | Employees | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 114,000 | 0 | - | 
| Dec 31, 2023 | 114,000 | -1,000 | -0.87% | 
| Dec 31, 2022 | 115,000 | 2,000 | 1.77% | 
| Dec 31, 2021 | 113,000 | 4,000 | 3.67% | 
| Dec 31, 2020 | 109,000 | 2,000 | 1.87% | 
| Dec 31, 2019 | 107,000 | 4,000 | 3.88% | 
| Dec 31, 2018 | 103,000 | 4,000 | 4.04% | 
| Dec 31, 2017 | 99,000 | 24,000 | 32.00% | 
| Dec 31, 2016 | 75,000 | 1,000 | 1.35% | 
| Dec 31, 2015 | 74,000 | -3,000 | -3.90% | 
| Dec 31, 2014 | 77,000 | 8,000 | 11.59% | 
| Dec 31, 2013 | 69,000 | -22,000 | -24.18% | 
| Dec 31, 2012 | 91,000 | 0 | - | 
| Dec 31, 2011 | 91,000 | 1,000 | 1.11% | 
| Dec 31, 2010 | 90,000 | 17,000 | 23.29% | 
| Dec 31, 2009 | 73,000 | 4,000 | 5.80% | 
| Dec 31, 2008 | 69,000 | 1,000 | 1.47% | 
| Dec 31, 2007 | 68,000 | 1,337 | 2.01% | 
| Dec 31, 2006 | 66,663 | 6,928 | 11.60% | 
| Dec 31, 2005 | 59,735 | -865 | -1.43% | 
| Dec 31, 2004 | 60,600 | -11,600 | -16.07% | 
| Dec 31, 2003 | 72,200 | 381 | 0.53% | 
| Dec 31, 2002 | 71,819 | 393 | 0.55% | 
| Dec 31, 2001 | 71,426 | 10,855 | 17.92% | 
| Dec 31, 2000 | 60,571 | 3,471 | 6.08% | 
| Dec 31, 1999 | 57,100 | 864 | 1.54% | 
| Dec 31, 1998 | 56,236 | 1,749 | 3.21% | 
| Dec 31, 1997 | 54,487 | 1,670 | 3.16% | 
| Dec 31, 1996 | 52,817 | 2,576 | 5.13% | 
| Dec 31, 1995 | 50,241 | 777 | 1.57% | 
| Dec 31, 1994 | 49,464 | -195 | -0.39% | 
| Dec 31, 1993 | 49,659 | - | - | 
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees | 
|---|---|
| UnitedHealth Group | 400,000 | 
| Johnson & Johnson | 138,100 | 
| Thermo Fisher Scientific | 125,000 | 
| AstraZeneca | 92,900 | 
| Novo Nordisk | 77,349 | 
| Novartis AG | 75,883 | 
| Merck & Co. | 75,000 | 
| AbbVie | 55,000 | 
ABT News
- 1 day ago - Abbott Showcases World's First Dual Chamber Leadless Pacemaker in National Media Tour Featuring Patient Story with YourUpdateTV - GlobeNewsWire
- 2 days ago - Best Dividend Kings: October 2025 - Seeking Alpha
- 10 days ago - Walmart to be first US retailer to sell Abbott's continuous glucose monitor, Axios reports - Reuters
- 13 days ago - Abbott: GLP-1 Beneficiary - A Dividend Raise May Be Coming - Seeking Alpha
- 15 days ago - These Analysts Revise Their Forecasts On Abbott Following Q3 Results - Benzinga
- 15 days ago - Abbott Laboratories Q3 2025 Earnings: Stable Growth Amid Tariff And China Headwinds - Seeking Alpha
- 16 days ago - Gold Gains Over 1%; Abbott Shares Fall After Q3 Results - Benzinga
- 16 days ago - Abbott Laboratories (ABT) Q3 2025 Earnings Call Transcript - Seeking Alpha